Cercar
01/08/2022
Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutanaeos inmunoglobulin in pediatric patients
Serra Font S., López-Granados L., Sisinni L., Serna Berna J.V., Martínez Martínez L., Fernández de Gamarra-Martínez E., de la Calle Martín O., Badell Serra I.. Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutanaeos inmunoglobulin in pediatric patients. ANALES DE PEDIATRIA. 2022; 97(2)DOI:10.1016/j.anpedi.2021.08.011. PMID:35869014. IF:2.100(Q3/6D).
01/05/2022
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Moreno-Martinez, E, de la Serna-Torroba, J, Escudero-Vilaplana, V, Hernandez-Rivas, JA, Sanchez-Cuervos, M, Sanchez-Hernandez, R. Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain. Farmacia Hospitalaria. 2022; 46(3)DOI:10.7399/fh.11829. PMID:36183205. IF:(Q/D).
01/04/2022
Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas
Serda, PC, Teres, R, Sebio, A, Bague, S, Orellana, R, Moreno, ME, Riba, M, Lopez-Pousa, A. Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas. ADVANCES IN THERAPY. 2022; 39(4)DOI:10.1007/s12325-022-02051-2. PMID:35129790. IF:3.800(Q2/4D).
01/04/2022
Risk factors associated with emergency service re-visits in frailty diabetic patients who consult for hypoglycaemia
Mas Malagarriga N., Ruiz Ramos J., Juanes Borrego A.M., Agra Montava I., Vega Hanna L., López Vinardell L., Puig Campmany M., Mangues Bafalluy M.A.. Risk factors associated with emergency service re-visits in frailty diabetic patients who consult for hypoglycaemia. Medicina De Familia-Semergen. 2022; 48(3)DOI:10.1016/j.semerg.2021.09.011. PMID:34848135. IF:(Q/D).